Victoria Gonzalez is a fourth year PhD student at the University of Saskatchewan, Canada, where her training is supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) fellowship. She is supervised by Dr. Arinjay Banerjee, where she explores the innate immune response towards emerging viruses and the consequences of infection in reservoir species (ie. bats) and spillover animals (ie. humans).  

In 2018, she obtained a BSc in Microbiology and Immunology from Dalhousie University, Canada, where her honours project was supervised by Dr. Kimberly Brewer and evaluated the effects of a novel immunotherapeutic in a murine model of ovarian cancer. In 2021, she completed a MSc in Infectious Diseases and One Health (IDOH) at the Université de Tours, la Universitat Autònoma de Barcelona, and the University of Edinburgh, where she was an Erasmus Mundus scholar. Her research assessed alternative vaccine strategies for SARS-CoV-2 spike peptides using the Rotavirus A vaccine platform and was conducted with Dr. Eleanor Gaunt at the Roslin Institute, Scotland. Victoria furthered her training in One Health by participating in the One Health European Joint Program offered at Wageningen University, Netherlands in 2020, and is currently the lead of the University of Saskatchewan’s One Health student committee.